Influence of Fibroblasts on Mammary Gland Development, Breast Cancer Microenvironment Remodeling, and Cancer Cell Dissemination

The stromal microenvironment regulates mammary gland development and tumorigenesis. In normal mammary glands, the stromal microenvironment encompasses the ducts and contains fibroblasts, the main regulators of branching morphogenesis. Understanding the way fibroblast signaling pathways regulate mammary gland development may offer insights into the mechanisms of breast cancer (BC) biology. In fact, the unregulated mammary fibroblast signaling pathways, associated with alterations in extracellular matrix (ECM) remodeling and branching morphogenesis, drive breast cancer microenvironment (BCM) remodeling and cancer growth. The BCM comprises a very heterogeneous tissue containing non-cancer stromal cells, namely, breast cancer-associated fibroblasts (BCAFs), which represent most of the tumor mass. Moreover, the different components of the BCM highly interact with cancer cells, thereby generating a tightly intertwined network. In particular, BC cells activate recruited normal fibroblasts in BCAFs, which, in turn, promote BCM remodeling and metastasis. Thus, comparing the roles of normal fibroblasts and BCAFs in the physiological and metastatic processes, could provide a deeper understanding of the signaling pathways regulating BC dissemination. Here, we review the latest literature describing the structure of the mammary gland and the BCM and summarize the influence of epithelial-mesenchymal transition (EpMT) and autophagy in BC dissemination. Finally, we discuss the roles of fibroblasts and BCAFs in mammary gland development and BCM remodeling, respectively.

[1]  Tamara L. Kinzer-Ursem,et al.  The Dynamic Relationship of Breast Cancer Cells and Fibroblasts in Fibronectin Accumulation at Primary and Metastatic Tumor Sites , 2020, Cancers.

[2]  T. Choi,et al.  Roles of Autophagy in Oxidative Stress , 2020, International journal of molecular sciences.

[3]  Austin E. Gillen,et al.  Fibroblast subtypes define a metastatic matrisome in breast cancer. , 2020, JCI insight.

[4]  A. Zannetti,et al.  Recruitment of stromal cells into tumour microenvironment promote the metastatic spread of breast cancer. , 2020, Seminars in cancer biology.

[5]  T. Wegman-Ostrosky,et al.  Tumor microenvironment differences between primary tumor and brain metastases , 2020, Journal of Translational Medicine.

[6]  D. García-Bernal,et al.  Autophagy in the Immunosuppressive Perivascular Microenvironment of Glioblastoma , 2019, Cancers.

[7]  Hung-Chi Cheng,et al.  Fibronectin in Cancer: Friend or Foe , 2019, Cells.

[8]  Michael K. Wendt,et al.  Transglutaminase-2 facilitates extracellular vesicle-mediated establishment of the metastatic niche , 2019, bioRxiv.

[9]  I. Meinhold-Heerlein,et al.  Molecular Targeting Therapy against EGFR Family in Breast Cancer: Progress and Future Potentials , 2019, Cancers.

[10]  G. Botti,et al.  Paracrine recruitment and activation of fibroblasts by c‐Myc expressing breast epithelial cells through the IGFs/IGF‐1R axis , 2019, International journal of cancer.

[11]  Qian Yang,et al.  Atypical ubiquitin-binding protein SHARPIN promotes breast cancer progression. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[12]  M. R. Ruocco,et al.  Development of a Stromal Microenvironment Experimental Model Containing Proto-Myofibroblast Like Cells and Analysis of Its Crosstalk with Melanoma Cells: A New Tool to Potentiate and Stabilize Tumor Suppressor Phenotype of Dermal Myofibroblasts , 2019, Cells.

[13]  P. Hao,et al.  Quantitative Phosphoproteomics Reveals System-Wide Phosphorylation Network Altered by Spry in Mouse Mammary Stromal Fibroblasts , 2019, International journal of molecular sciences.

[14]  Michael K. Wendt,et al.  Dynamic transition of the blood-brain barrier in the development of non-small cell lung cancer brain metastases , 2019, Oncotarget.

[15]  J. Bamber,et al.  Investigating the Contribution of Collagen to the Tumor Biomechanical Phenotype with Non-invasive Magnetic Resonance Elastography. , 2019, Cancer research.

[16]  A. Singh,et al.  Inflammation, immunosuppressive microenvironment and breast cancer: opportunities for cancer prevention and therapy. , 2019, Annals of translational medicine.

[17]  J. Condeelis,et al.  Tumor Microenvironment of Metastasis (TMEM) Doorways Are Restricted to the Blood Vessel Endothelium in Both Primary Breast Cancers and Their Lymph Node Metastases , 2019, Cancers.

[18]  N. Erez,et al.  NLRP3 inflammasome in fibroblasts links tissue damage with inflammation in breast cancer progression and metastasis , 2019, Nature Communications.

[19]  R. Sharan,et al.  Evolution of metastases-associated fibroblasts in the lung microenvironment is driven by stage-specific transcriptional plasticity , 2019 .

[20]  Sylvain D. Vallet,et al.  Lysyl oxidases: from enzyme activity to extracellular matrix cross-links. , 2019, Essays in biochemistry.

[21]  M. Pollak,et al.  Metastatic Breast Carcinoma–Associated Fibroblasts Have Enhanced Protumorigenic Properties Related to Increased IGF2 Expression , 2019, Clinical Cancer Research.

[22]  K. Britt,et al.  The Immune Microenvironment of Breast Cancer Progression , 2019, Cancers.

[23]  C. Springer,et al.  2-Aminomethylene-5-sulfonylthiazole Inhibitors of Lysyl Oxidase (LOX) and LOXL2 Show Significant Efficacy in Delaying Tumor Growth , 2019, Journal of medicinal chemistry.

[24]  E. Tajara,et al.  Cellular Interactions in the Tumor Microenvironment: The Role of Secretome , 2019, Journal of Cancer.

[25]  Y. Miyagi,et al.  Stromal fibroblasts induce metastatic tumor cell clusters via epithelial–mesenchymal plasticity , 2019, Life Science Alliance.

[26]  D. Welch,et al.  Defining the Hallmarks of Metastasis. , 2019, Cancer research.

[27]  J. Schneider,et al.  Breast Cancer Tumor Stroma: Cellular Components, Phenotypic Heterogeneity, Intercellular Communication, Prognostic Implications and Therapeutic Opportunities , 2019, Cancers.

[28]  W. Coleman Breast Ductal Carcinoma in Situ: Precursor to Invasive Breast Cancer. , 2019, The American journal of pathology.

[29]  M. R. Ruocco,et al.  Mitochondrial Flexibility of Breast Cancers: A Growth Advantage and a Therapeutic Opportunity , 2019, Cells.

[30]  K. Taniguchi,et al.  The Sprouty/Spred family as tumor suppressors: Coming of age , 2019, Cancer science.

[31]  Michael K. Wendt,et al.  Spleen Tyrosine Kinase-Mediated Autophagy Is Required for Epithelial-Mesenchymal Plasticity and Metastasis in Breast Cancer. , 2019, Cancer research.

[32]  E. Sonnhammer,et al.  A Novel ACKR2-Dependent Role of Fibroblast-Derived CXCL14 in Epithelial-to-Mesenchymal Transition and Metastasis of Breast Cancer , 2019, Clinical Cancer Research.

[33]  Pere Roca-Cusachs,et al.  Integrin Binding Dynamics Modulate Ligand-Specific Mechanosensing in Mammary Gland Fibroblasts , 2019, bioRxiv.

[34]  M. Dozmorov,et al.  Syndecan-1 facilitates breast cancer metastasis to the brain , 2019, bioRxiv.

[35]  C. Blanpain,et al.  EMT Transition States during Tumor Progression and Metastasis. , 2019, Trends in cell biology.

[36]  K. Eto,et al.  SHARPIN at the nexus of integrin, immune, and inflammatory signaling in human platelets , 2019, Proceedings of the National Academy of Sciences.

[37]  E. White,et al.  Autophagy inhibition specifically promotes epithelial-mesenchymal transition and invasion in RAS-mutated cancer cells , 2019, Autophagy.

[38]  Dan Yang,et al.  Cancer-associated fibroblast (CAF)-derived IL32 promotes breast cancer cell invasion and metastasis via integrin β3-p38 MAPK signalling. , 2019, Cancer letters.

[39]  C. Eaves,et al.  Transcriptional regulation of normal human mammary cell heterogeneity and its perturbation in breast cancer , 2019, The EMBO journal.

[40]  A. Mohanty,et al.  Molecular mechanism of mammary gland involution: An update. , 2019, Developmental biology.

[41]  J. Sumbal,et al.  FGF signaling in mammary gland fibroblasts regulates multiple fibroblast functions and mammary epithelial morphogenesis , 2019, Development.

[42]  Michael C. Ostrowski,et al.  Stromal PTEN Regulates Extracellular Matrix Organization in the Mammary Gland , 2018, Neoplasia.

[43]  A. Simon,et al.  Autophagy in the renewal, differentiation and homeostasis of immune cells , 2018, Nature Reviews Immunology.

[44]  Yu-qin Pan,et al.  The pro-metastasis effect of circANKS1B in breast cancer , 2018, Molecular Cancer.

[45]  M. Renna,et al.  Revisiting Bacterial Ubiquitin Ligase Effectors: Weapons for Host Exploitation , 2018, International journal of molecular sciences.

[46]  C. Yun,et al.  The Roles of Autophagy in Cancer , 2018, International journal of molecular sciences.

[47]  Jieqing Li,et al.  Celecoxib in breast cancer prevention and therapy , 2018, Cancer management and research.

[48]  A. E. del Río Hernández,et al.  Role of Extracellular Matrix in Development and Cancer Progression , 2018, International journal of molecular sciences.

[49]  S. K. Hemalatha,et al.  Brcal Defective Breast Cancer Cells Induce in vitro Transformation of Cancer Associated Fibroblasts (CAFs) to Metastasis Associated Fibroblasts (MAF) , 2018, Scientific Reports.

[50]  M. R. Ruocco,et al.  Involvement of Breast Cancer-Associated Fibroblasts in Tumor Development, Therapy Resistance and Evaluation of Potential Therapeutic Strategies. , 2018, Current medicinal chemistry.

[51]  Y. Liu,et al.  Extracellular ATP drives breast cancer cell migration and metastasis via S100A4 production by cancer cells and fibroblasts. , 2018, Cancer letters.

[52]  Michael K. Wendt,et al.  Autocrine Fibronectin Inhibits Breast Cancer Metastasis , 2018, Molecular Cancer Research.

[53]  M. R. Ruocco,et al.  Metabolic Reprogramming of Cancer Associated Fibroblasts: The Slavery of Stromal Fibroblasts , 2018, BioMed research international.

[54]  E. Furth,et al.  EMT Subtype Influences Epithelial Plasticity and Mode of Cell Migration. , 2018, Developmental cell.

[55]  Michael K. Wendt,et al.  Pyruvate carboxylase supports the pulmonary tropism of metastatic breast cancer , 2018, Breast Cancer Research.

[56]  E. Turley,et al.  Hyaluronan, Cancer-Associated Fibroblasts and the Tumor Microenvironment in Malignant Progression , 2018, Front. Cell Dev. Biol..

[57]  F. Pouliot,et al.  Exosomes Induce Fibroblast Differentiation into Cancer-Associated Fibroblasts through TGFβ Signaling , 2018, Molecular Cancer Research.

[58]  A. Adamczyk,et al.  Podoplanin-positive Cancer-associated Stromal Fibroblasts in Primary Tumor and Synchronous Lymph Node Metastases of HER2-overexpressing Breast Carcinomas. , 2018, Anticancer research.

[59]  J. Condeelis,et al.  Chemotherapy-induced metastasis: mechanisms and translational opportunities , 2018, Clinical & Experimental Metastasis.

[60]  I. Amelio,et al.  The hypoxic tumour microenvironment , 2018, Oncogenesis.

[61]  M. Mallardo,et al.  The expression of inhibitor of bruton’s tyrosine kinase gene is progressively up regulated in the clinical course of chronic lymphocytic leukaemia conferring resistance to apoptosis , 2018, Cell Death & Disease.

[62]  Y. Boucher,et al.  The crosstalk between breast carcinoma-associated fibroblasts and cancer cells promotes RhoA-dependent invasion via IGF-1 and PAI-1 , 2017, Oncotarget.

[63]  Michael K. Wendt,et al.  Inhibition of pyruvate carboxylase by 1α,25-dihydroxyvitamin D promotes oxidative stress in early breast cancer progression. , 2017, Cancer letters.

[64]  R. Gray,et al.  A metastasis biomarker (MetaSite Breast™ Score) is associated with distant recurrence in hormone receptor-positive, HER2-negative early-stage breast cancer , 2017, npj Breast Cancer.

[65]  A. Mohanty,et al.  NEW INSIGHTS OF MAMMARY GLAND DURING DIFFERENT STAGES OF DEVELOPMENT , 2017 .

[66]  Pengcheng Zhang,et al.  Regulating cancer associated fibroblasts with losartan-loaded injectable peptide hydrogel to potentiate chemotherapy in inhibiting growth and lung metastasis of triple negative breast cancer. , 2017, Biomaterials.

[67]  J. Sundberg,et al.  Integrin beta 1 inhibition alleviates the chronic hyperproliferative dermatitis phenotype of SHARPIN-deficient mice , 2017, PloS one.

[68]  Michael K. Wendt,et al.  Regulation of epithelial-mesenchymal transition and metastasis by TGF-β, P-bodies, and autophagy , 2017, Oncotarget.

[69]  J. Ryś,et al.  Podoplanin increases the migration of human fibroblasts and affects the endothelial cell network formation: A possible role for cancer-associated fibroblasts in breast cancer progression , 2017, PloS one.

[70]  S. Rey,et al.  Hypoxic pathobiology of breast cancer metastasis. , 2017, Biochimica et biophysica acta. Reviews on cancer.

[71]  M. Lewis,et al.  New paradigms for the Hedgehog signaling network in mammary gland development and breast Cancer. , 2017, Biochimica et biophysica acta. Reviews on cancer.

[72]  M. R. Ruocco,et al.  Generation and analysis of spheroids from human primary skin myofibroblasts: an experimental system to study myofibroblasts deactivation , 2017, Cell Death Discovery.

[73]  R. Hass,et al.  Breast Carcinoma: From Initial Tumor Cell Detachment to Settlement at Secondary Sites , 2017, BioMed research international.

[74]  D. Gourdon,et al.  Breast cancer cells alter the dynamics of stromal fibronectin-collagen interactions. , 2017, Matrix biology : journal of the International Society for Matrix Biology.

[75]  Jonathan J. Chen,et al.  Synergistic IL-6 and IL-8 paracrine signalling pathway infers a strategy to inhibit tumour cell migration , 2017, Nature Communications.

[76]  Michael C. Ostrowski,et al.  Stromal PDGFR-α Activation Enhances Matrix Stiffness, Impedes Mammary Ductal Development, and Accelerates Tumor Growth , 2017, Neoplasia.

[77]  Yonglei Liu,et al.  Down-regulation of miR-29b in carcinoma associated fibroblasts promotes cell growth and metastasis of breast cancer , 2017, Oncotarget.

[78]  X. Jiang,et al.  Aberrant low expression of p85α in stromal fibroblasts promotes breast cancer cell metastasis through exosome-mediated paracrine Wnt10b , 2017, Oncogene.

[79]  V. Ponomarev,et al.  Inflammatory peroxidases promote breast cancer progression in mice via regulation of the tumour microenvironment. , 2017, International journal of oncology.

[80]  J. Kzhyshkowska,et al.  Intratumoral heterogeneity of macrophages and fibroblasts in breast cancer is associated with the morphological diversity of tumor cells and contributes to lymph node metastasis. , 2017, Immunobiology.

[81]  Y. Xuan,et al.  Tenascin C is a prognostic determinant and potential cancer-associated fibroblasts marker for breast ductal carcinoma. , 2017, Experimental and molecular pathology.

[82]  P. Spellman,et al.  Physiologically activated mammary fibroblasts promote postpartum mammary cancer. , 2017, JCI insight.

[83]  W. Woodward,et al.  Inflammatory breast cancer: a model for investigating cluster-based dissemination , 2017, bioRxiv.

[84]  J. Waisman,et al.  Human brain metastatic stroma attracts breast cancer cells via chemokines CXCL16 and CXCL12 , 2017, npj Breast Cancer.

[85]  Chuang Chen,et al.  Breast cancer subtypes predict the preferential site of distant metastases: a SEER based study , 2017, Oncotarget.

[86]  Abigail Hielscher,et al.  Fibronectin: How Its Aberrant Expression in Tumors May Improve Therapeutic Targeting , 2017, Journal of Cancer.

[87]  J. Erler,et al.  Pre-clinical evaluation of small molecule LOXL2 inhibitors in breast cancer , 2017, Oncotarget.

[88]  M. Lewis,et al.  The Terminal End Bud: the Little Engine that Could , 2017, Journal of Mammary Gland Biology and Neoplasia.

[89]  B. Krishnamachary,et al.  Breast cancer cell cyclooxygenase-2 expression alters extracellular matrix structure and function and numbers of cancer associated fibroblasts , 2017, Oncotarget.

[90]  A. Mencalha,et al.  NF-kappaB Is Involved in the Regulation of EMT Genes in Breast Cancer Cells , 2017, PloS one.

[91]  Jun Liu,et al.  Clinicopathological and prognostic significance of COX-2 immunohistochemical expression in breast cancer: a meta-analysis , 2016, Oncotarget.

[92]  J. Sundberg,et al.  SHARPIN regulates collagen architecture and ductal outgrowth in the developing mouse mammary gland , 2016, The EMBO journal.

[93]  V. Weaver,et al.  From transformation to metastasis: deconstructing the extracellular matrix in breast cancer , 2016, Cancer and Metastasis Reviews.

[94]  A. Ciarrocchi,et al.  Autophagy and epithelial–mesenchymal transition: an intricate interplay in cancer , 2016, Cell Death & Disease.

[95]  G. Semenza,et al.  Hypoxia-Inducible Factors: Master Regulators of Cancer Progression. , 2016, Trends in cancer.

[96]  Pang-Kuo Lo,et al.  A High-Fat Diet Promotes Mammary Gland Myofibroblast Differentiation through MicroRNA 140 Downregulation , 2016, Molecular and Cellular Biology.

[97]  O. Petersen,et al.  Evidence of two distinct functionally specialized fibroblast lineages in breast stroma , 2016, Breast Cancer Research.

[98]  Z. Werb,et al.  Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer , 2016, Oncotarget.

[99]  O. Klein,et al.  SPRY1 regulates mammary epithelial morphogenesis by modulating EGFR-dependent stromal paracrine signaling and ECM remodeling , 2016, Proceedings of the National Academy of Sciences.

[100]  M. R. Ruocco,et al.  Cancer: An Oxidative Crosstalk between Solid Tumor Cells and Cancer Associated Fibroblasts , 2016, BioMed research international.

[101]  C. Münz Autophagy proteins in antigen processing for presentation on MHC molecules , 2016, Immunological reviews.

[102]  J. Condeelis,et al.  Signatures of breast cancer metastasis at a glance , 2016, Journal of Cell Science.

[103]  H. Kiaris,et al.  A CCL8 gradient drives breast cancer cell dissemination , 2016, Oncogene.

[104]  F. Gu,et al.  Breast cancer-associated fibroblasts: their roles in tumor initiation, progression and clinical applications , 2016, Frontiers of Medicine.

[105]  J. Frost,et al.  Minireview: Mouse Models of Rho GTPase Function in Mammary Gland Development, Tumorigenesis, and Metastasis. , 2016, Molecular endocrinology.

[106]  T. Oskarsson,et al.  The extracellular matrix in breast cancer. , 2016, Advanced drug delivery reviews.

[107]  R. Buchsbaum,et al.  The fibroblast Tiam1-osteopontin pathway modulates breast cancer invasion and metastasis , 2016, Breast Cancer Research.

[108]  R. Buchsbaum,et al.  Breast Cancer-Associated Fibroblasts: Where We Are and Where We Need to Go , 2016, Cancers.

[109]  S. Gerecht,et al.  Fibronectin Deposition Participates in Extracellular Matrix Assembly and Vascular Morphogenesis , 2016, PloS one.

[110]  J. Erler,et al.  Lysyl Oxidase, a Targetable Secreted Molecule Involved in Cancer Metastasis. , 2016, Cancer research.

[111]  R. Datar,et al.  Identification of Cancer-Associated Fibroblasts in Circulating Blood from Patients with Metastatic Breast Cancer. , 2015, Cancer research.

[112]  Chang S. Chan,et al.  Autophagy, Metabolism, and Cancer , 2015, Clinical Cancer Research.

[113]  Catherine C. Park,et al.  Human breast cancer invasion and aggression correlates with ECM stiffening and immune cell infiltration. , 2015, Integrative biology : quantitative biosciences from nano to macro.

[114]  C. Lovly,et al.  Molecular Pathways: Clinical Applications and Future Direction of Insulin-like Growth Factor-1 Receptor Pathway Blockade , 2015, Clinical Cancer Research.

[115]  Yarong Wang,et al.  Real-Time Imaging Reveals Local, Transient Vascular Permeability, and Tumor Cell Intravasation Stimulated by TIE2hi Macrophage-Derived VEGFA. , 2015, Cancer discovery.

[116]  A. Hjerpe,et al.  Syndecan-1 in Cancer: Implications for Cell Signaling, Differentiation, and Prognostication , 2015, Disease markers.

[117]  Bo Ri Seo,et al.  Obesity-dependent changes in interstitial ECM mechanics promote breast tumorigenesis , 2015, Science Translational Medicine.

[118]  Bonnie F. Sloane,et al.  Il-6 signaling between ductal carcinoma in situ cells and carcinoma-associated fibroblasts mediates tumor cell growth and migration , 2015, BMC Cancer.

[119]  Shukun Tang,et al.  Stromal miR-200s contribute to breast cancer cell invasion through CAF activation and ECM remodeling , 2015, Cell Death and Differentiation.

[120]  G. Bauerschmitz,et al.  Inhibition of SDF-1/CXCR4-induced epithelial–mesenchymal transition by kisspeptin-10 , 2015, Breast Cancer Research and Treatment.

[121]  D. Radisky,et al.  Matrix metalloproteinases as breast cancer drivers and therapeutic targets. , 2015, Frontiers in bioscience.

[122]  R. Linding,et al.  The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase , 2015, Nature.

[123]  Xinbing Sui,et al.  The role of STAT3 in autophagy , 2015, Autophagy.

[124]  G. Cuda,et al.  CRL3IBTK Regulates the Tumor Suppressor Pdcd4 through Ubiquitylation Coupled to Proteasomal Degradation , 2015, The Journal of Biological Chemistry.

[125]  Seamus J. Martin,et al.  Autophagy in malignant transformation and cancer progression , 2015, The EMBO journal.

[126]  Zong-fang Li,et al.  GPER in CAFs regulates hypoxia-driven breast cancer invasion in a CTGF-dependent manner. , 2015, Oncology reports.

[127]  M. Bissell,et al.  Mammary gland development: cell fate specification, stem cells and the microenvironment , 2015, Development.

[128]  Michael D. Brooks,et al.  Epithelial-mesenchymal plasticity of breast cancer stem cells: implications for metastasis and therapeutic resistance. , 2015, Current pharmaceutical design.

[129]  H. van Dam,et al.  Genetic depletion and pharmacological targeting of αv integrin in breast cancer cells impairs metastasis in zebrafish and mouse xenograft models , 2015, Breast Cancer Research.

[130]  Joan G. Jones,et al.  TMEM: a novel breast cancer dissemination marker for the assessment of metastatic risk. , 2015, Biomarkers in medicine.

[131]  J. Makki,et al.  Diversity of Breast Carcinoma: Histological Subtypes and Clinical Relevance , 2015, Clinical medicine insights. Pathology.

[132]  Byoungduck Park,et al.  Baohuoside I suppresses invasion of cervical and breast cancer cells through the downregulation of CXCR4 chemokine receptor expression. , 2014, Biochemistry.

[133]  Gretchen L. Gierach,et al.  Terminal duct lobular unit involution of the normal breast: implications for breast cancer etiology. , 2014, Journal of the National Cancer Institute.

[134]  Kelvin K. Tsai,et al.  Cancer/stroma interplay via cyclooxygenase-2 and indoleamine 2,3-dioxygenase promotes breast cancer progression , 2014, Breast Cancer Research.

[135]  C. Bancone,et al.  Analysis of Extracellular Superoxide Dismutase and Akt in Ascending Aortic Aneurysm With Tricuspid or Bicuspid Aortic Valve , 2014, European journal of histochemistry : EJH.

[136]  Robin L. Anderson,et al.  Stromal Fibroblasts and the Immune Microenvironment: Partners in Mammary Gland Biology and Pathology? , 2014, Journal of Mammary Gland Biology and Neoplasia.

[137]  Pengfei Lu,et al.  Modulation of Fibroblast Growth Factor Signaling Is Essential for Mammary Epithelial Morphogenesis , 2014, PloS one.

[138]  E. Cukierman,et al.  The wound healing, chronic fibrosis, and cancer progression triad. , 2014, Physiological genomics.

[139]  F. Vizoso,et al.  Expression and prognostic significance of fibronectin and matrix metalloproteases in breast cancer metastasis , 2014, Histopathology.

[140]  Z. Wang,et al.  Antitumour activity of the recombination polypeptide GST-NT21MP is mediated by inhibition of CXCR4 pathway in breast cancer , 2014, British journal of cancer.

[141]  Yu-mei Feng,et al.  Cancer-associated fibroblasts induce epithelial–mesenchymal transition of breast cancer cells through paracrine TGF-β signalling , 2013, British Journal of Cancer.

[142]  N. Hogg,et al.  SHARPIN regulates uropod detachment in migrating lymphocytes. , 2013, Cell reports.

[143]  Jing Yang,et al.  Epithelial–mesenchymal plasticity in carcinoma metastasis , 2013, Genes & development.

[144]  S. Qiu,et al.  Autophagy inhibition suppresses pulmonary metastasis of HCC in mice via impairing anoikis resistance and colonization of HCC cells , 2013, Autophagy.

[145]  M. Maggiolini,et al.  HIF-1α/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs) , 2013, Breast Cancer Research.

[146]  R. S. Johnson,et al.  Tumour oxygenation: implications for breast cancer prognosis , 2013, Journal of internal medicine.

[147]  R. Lonser,et al.  Characterization of the blood-brain barrier of metastatic and primary malignant neoplasms. , 2013, Journal of neurosurgery.

[148]  A. Rossi,et al.  Eukaryotic Initiation Factor 4H Is under Transcriptional Control of p65/NF-κB , 2013, PloS one.

[149]  Michael K. Wendt,et al.  Epithelial to Mesenchymal Transition Promotes Breast Cancer Progression via a Fibronectin-dependent STAT3 Signaling Pathway* , 2013, The Journal of Biological Chemistry.

[150]  Han-Sung Jung,et al.  Pleiotropic Functions of Fibroblast Growth Factor Signaling in Embryonic Mammary Gland Development , 2013, Journal of Mammary Gland Biology and Neoplasia.

[151]  D. Fletcher,et al.  Patterned Collagen Fibers Orient Branching Mammary Epithelium through Distinct Signaling Modules , 2013, Current Biology.

[152]  T. Tan,et al.  Epithelial-to-mesenchymal transition and autophagy induction in breast carcinoma promote escape from T-cell-mediated lysis. , 2013, Cancer research.

[153]  M. R. Ruocco,et al.  Markers of mitochondrial dysfunction during the diclofenac-induced apoptosis in melanoma cell lines. , 2013, Biochimie.

[154]  K. Francis,et al.  Enhanced detection of myeloperoxidase activity in deep tissues through luminescent excitation of near-infrared nanoparticles , 2013, Nature Medicine.

[155]  B. Parvin,et al.  Breast fibroblasts modulate early dissemination, tumorigenesis, and metastasis through alteration of extracellular matrix characteristics. , 2013, Neoplasia.

[156]  Fei Zhang,et al.  Aquaporin3 Is Required for FGF-2-Induced Migration of Human Breast Cancers , 2013, PloS one.

[157]  S. Hilsenbeck,et al.  Fibroblast Growth Factor Receptor Signaling Is Essential for Normal Mammary Gland Development and Stem Cell Function , 2013, Stem cells.

[158]  F. Rösel,et al.  Mammary fibroblasts regulate morphogenesis of normal and tumorigenic breast epithelial cells by mechanical and paracrine signals. , 2012, Cancer letters.

[159]  J. Wrana,et al.  Exosomes Mediate Stromal Mobilization of Autocrine Wnt-PCP Signaling in Breast Cancer Cell Migration , 2012, Cell.

[160]  L. Galluzzi,et al.  Cytoplasmic STAT3 represses autophagy by inhibiting PKR activity. , 2012, Molecular cell.

[161]  C. Gialeli,et al.  Expression of matrix macromolecules and functional properties of breast cancer cells are modulated by the bisphosphonate zoledronic acid. , 2012, Biochimica et biophysica acta.

[162]  Yanqiu Zhao,et al.  TISSUE-SPECIFIC STEM CELLS Inhibition of TGF-b/Smad Signaling by BAMBI Blocks Differentiation of Human Mesenchymal Stem Cells to Carcinoma-Associated Fibroblasts and Abolishes Their Protumor Effects , 2012 .

[163]  Meiyappan Solaiyappan,et al.  Collagen I fiber density increases in lymph node positive breast cancers: pilot study , 2012, Journal of biomedical optics.

[164]  P. Scherer,et al.  Adipocyte-derived endotrophin promotes malignant tumor progression. , 2012, The Journal of clinical investigation.

[165]  M. Detmar,et al.  Interaction of tumor cells and lymphatic vessels in cancer progression , 2012, Oncogene.

[166]  R. Jain,et al.  TGF-β blockade improves the distribution and efficacy of therapeutics in breast carcinoma by normalizing the tumor stroma , 2012, Proceedings of the National Academy of Sciences.

[167]  Y. DeClerck Desmoplasia: a response or a niche? , 2012, Cancer discovery.

[168]  H. Oh,et al.  STAT3 Protein Interacts with Class O Forkhead Transcription Factors in the Cytoplasm and Regulates Nuclear/Cytoplasmic Localization of FoxO1 and FoxO3a Proteins in CD4+ T Cells* , 2012, The Journal of Biological Chemistry.

[169]  C. Andl,et al.  The regulation of cell-cell adhesion during epithelial-mesenchymal transition, motility and tumor progression , 2012, Cell adhesion & migration.

[170]  L. Hinck,et al.  Mammary gland development , 2012, Wiley interdisciplinary reviews. Developmental biology.

[171]  J. Sleeman The metastatic niche and stromal progression , 2012, Cancer and Metastasis Reviews.

[172]  P. Carmeliet,et al.  SnapShot: Tumor Angiogenesis , 2012, Cell.

[173]  N. Cho,et al.  Invasive breast cancer induces laminin-332 upregulation and integrin β4 neoexpression in myofibroblasts to confer an anoikis-resistant phenotype during tissue remodeling , 2012, Breast Cancer Research.

[174]  W. Ye,et al.  CCL2 mediates cross-talk between cancer cells and stromal fibroblasts that regulates breast cancer stem cells. , 2012, Cancer research.

[175]  Joo H. Kang,et al.  Inhibition of mammary tumor growth using lysyl oxidase-targeting nanoparticles to modify extracellular matrix. , 2012, Nano letters.

[176]  Matthew W. Conklin,et al.  Why the stroma matters in breast cancer , 2012, Cell adhesion & migration.

[177]  D. Newgreen,et al.  Contribution of Fibroblast and Mast Cell (Afferent) and Tumor (Efferent) IL-6 Effects within the Tumor Microenvironment , 2012, Cancer Microenvironment.

[178]  Z. Werb,et al.  The extracellular matrix: A dynamic niche in cancer progression , 2012, The Journal of cell biology.

[179]  O. Kallioniemi,et al.  SHARPIN is an endogenous inhibitor of β1-integrin activation , 2011, Nature Cell Biology.

[180]  M. R. Ruocco,et al.  Analysis of extracellular superoxide dismutase in fibroblasts from patients with systemic sclerosis. , 2011, Journal of biological regulators and homeostatic agents.

[181]  N. Frangogiannis,et al.  TGF-β signaling in fibrosis , 2011, Growth factors.

[182]  F. Kraeber-Bodéré,et al.  Syndecan-1 Antigen, a Promising New Target for Triple-negative Breast Cancer Immuno-pet and Radioimmunotherapy. a Preclinical Study on Mda-mb-468 Xenograft Tumors , 2022 .

[183]  Scott E. Kern,et al.  Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis , 2011, Nature.

[184]  Y. Eishi,et al.  Autophagy-deficient mice develop multiple liver tumors. , 2011, Genes & development.

[185]  David Beebe,et al.  Syndecan-1 in breast cancer stroma fibroblasts regulates extracellular matrix fiber organization and carcinoma cell motility. , 2011, The American journal of pathology.

[186]  F. Pépin,et al.  Claudin-2 is selectively enriched in and promotes the formation of breast cancer liver metastases through engagement of integrin complexes , 2011, Oncogene.

[187]  Paolo P. Provenzano,et al.  Aligned Collagen Is a Prognostic Signature for Survival in Human Breast Carcinoma Address Reprint Requests to See Related Commentary on Page 966 , 2022 .

[188]  J. Cheng,et al.  Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL–RANK signalling , 2011, Nature.

[189]  F. Sotgia,et al.  Caveolin-1 and mitochondrial SOD2 (MnSOD) function as tumor suppressors in the stromal microenvironment , 2011, Cancer biology & therapy.

[190]  R. Jain,et al.  Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors , 2011, Proceedings of the National Academy of Sciences.

[191]  D. Radisky,et al.  Microenvironmental Influences that Drive Progression from Benign Breast Disease to Invasive Breast Cancer , 2010, Journal of Mammary Gland Biology and Neoplasia.

[192]  G. Sethi,et al.  Butein downregulates chemokine receptor CXCR4 expression and function through suppression of NF-κB activation in breast and pancreatic tumor cells. , 2010, Biochemical pharmacology.

[193]  J. Condeelis,et al.  Metastasis: tumor cells becoming MENAcing. , 2010, Trends in cell biology.

[194]  Kornelia Polyak,et al.  The role of the microenvironment in mammary gland development and cancer. , 2010, Cold Spring Harbor perspectives in biology.

[195]  Robert A. Weinberg,et al.  Autocrine TGF-β and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts , 2010, Proceedings of the National Academy of Sciences.

[196]  F. Schmitt,et al.  Angiogenesis and Breast Cancer , 2010, Journal of oncology.

[197]  Mikala Egeblad,et al.  Dynamic interplay between the collagen scaffold and tumor evolution. , 2010, Current opinion in cell biology.

[198]  Erin J. McCave,et al.  The Normal Microenvironment Directs Mammary Gland Development , 2010, Journal of Mammary Gland Biology and Neoplasia.

[199]  Z. Werb,et al.  Matrix Metalloproteinases: Regulators of the Tumor Microenvironment , 2010, Cell.

[200]  A. Tsirigos,et al.  Transcriptional evidence for the "Reverse Warburg Effect" in human breast cancer tumor stroma and metastasis: Similarities with oxidative stress, inflammation, Alzheimer's disease, and "Neuron-Glia Metabolic Coupling" , 2010, Aging.

[201]  A. Purushothaman,et al.  Heparanase-enhanced shedding of syndecan-1 by myeloma cells promotes endothelial invasion and angiogenesis. , 2010, Blood.

[202]  Akira Oshima,et al.  Transient Tumor-Fibroblast Interactions Increase Tumor Cell Malignancy by a TGF-β Mediated Mechanism in a Mouse Xenograft Model of Breast Cancer , 2010, PloS one.

[203]  D. Ribatti,et al.  Targeting tumor lymphangiogenesis: an update. , 2010, Current medicinal chemistry.

[204]  Bonnie F. Sloane,et al.  Fibroblast hepatocyte growth factor promotes invasion of human mammary ductal carcinoma in situ. , 2009, Cancer research.

[205]  Mikala Egeblad,et al.  Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling , 2009, Cell.

[206]  Metin N. Gurcan,et al.  Pten in Stromal Fibroblasts Suppresses Mammary Epithelial Tumors , 2009, Nature.

[207]  C. Brinckerhoff,et al.  CXCR4 and Matrix Metalloproteinase-1 Are Elevated in Breast Carcinoma–Associated Fibroblasts and in Normal Mammary Fibroblasts Exposed to Factors Secreted by Breast Cancer Cells , 2009, Molecular Cancer Research.

[208]  Raghu Kalluri,et al.  EMT: when epithelial cells decide to become mesenchymal-like cells. , 2009, The Journal of clinical investigation.

[209]  J. Pringle,et al.  Tumour-associated tenascin-C isoforms promote breast cancer cell invasion and growth by matrix metalloproteinase-dependent and independent mechanisms , 2009, Breast Cancer Research.

[210]  Bethan Psaila,et al.  The metastatic niche: adapting the foreign soil , 2009, Nature Reviews Cancer.

[211]  K. Polyak,et al.  Role of COX-2 in epithelial–stromal cell interactions and progression of ductal carcinoma in situ of the breast , 2009, Proceedings of the National Academy of Sciences.

[212]  F. Vizoso,et al.  Comparative analysis and clinical value of the expression of metalloproteases and their inhibitors by intratumor stromal fibroblasts and those at the invasive front of breast carcinomas , 2009, Breast Cancer Research and Treatment.

[213]  Gerhard Christofori,et al.  EMT, the cytoskeleton, and cancer cell invasion , 2009, Cancer and Metastasis Reviews.

[214]  A. Molinolo,et al.  Carcinoma‐associated fibroblasts activate progesterone receptors and induce hormone independent mammary tumor growth: A role for the FGF‐2/FGFR‐2 axis , 2008, International journal of cancer.

[215]  F. Portillo,et al.  Transcriptional regulation of cell polarity in EMT and cancer , 2008, Oncogene.

[216]  T. Rosol,et al.  Fibroblasts isolated from common sites of breast cancer metastasis enhance cancer cell growth rates and invasiveness in an interleukin-6-dependent manner. , 2008, Cancer Research.

[217]  Z. Werb,et al.  Genetic mosaic analysis reveals FGF receptor 2 function in terminal end buds during mammary gland branching morphogenesis. , 2008, Developmental biology.

[218]  Karen Plaut,et al.  Cancer associated fibroblasts stimulated by transforming growth factor beta1 (TGF-β1) increase invasion rate of tumor cells: a population study , 2008, Breast Cancer Research and Treatment.

[219]  R. Stupp,et al.  Tenascin‐W, a new marker of cancer stroma, is elevated in sera of colon and breast cancer patients , 2008, International journal of cancer.

[220]  Johanna Andrae,et al.  Role of platelet-derived growth factors in physiology and medicine. , 2008, Genes & development.

[221]  N. Karamanos,et al.  Imatinib Mesylate Inhibits Proliferation and Exerts an Antifibrotic Effect in Human Breast Stroma Fibroblasts , 2008, Molecular Cancer Research.

[222]  C. Rueden,et al.  Bmc Medicine Collagen Density Promotes Mammary Tumor Initiation and Progression , 2022 .

[223]  Andrew J Ewald,et al.  Collective epithelial migration and cell rearrangements drive mammary branching morphogenesis. , 2008, Developmental cell.

[224]  C. Watson,et al.  Mammary development in the embryo and adult: a journey of morphogenesis and commitment , 2008, Development.

[225]  R. Eils,et al.  Systemic spread is an early step in breast cancer. , 2008, Cancer cell.

[226]  Hyunsuk Shim,et al.  Discovery of small molecule CXCR4 antagonists. , 2007, Journal of medicinal chemistry.

[227]  R. Walker,et al.  Intrinsic genetic characteristics determine tumor-modifying capacity of fibroblasts: matrix metalloproteinase-3 5A/5A genotype enhances breast cancer cell invasion , 2007, Breast Cancer Research.

[228]  C. Ruiz,et al.  Tenascin-W is a novel marker for activated tumor stroma in low-grade human breast cancer and influences cell behavior. , 2007, Cancer research.

[229]  Paula D. Bos,et al.  Mediators of vascular remodelling co-opted for sequential steps in lung metastasis , 2007, Nature.

[230]  Crispin J. Miller,et al.  Relation of a hypoxia metagene derived from head and neck cancer to prognosis of multiple cancers. , 2007, Cancer research.

[231]  D. Newgreen,et al.  Induction of epithelial to mesenchymal transition in PMC42-LA human breast carcinoma cells by carcinoma-associated fibroblast secreted factors , 2007, Breast Cancer Research.

[232]  Paolo P. Provenzano,et al.  Collagen reorganization at the tumor-stromal interface facilitates local invasion , 2006, BMC medicine.

[233]  J. Pollard,et al.  Macrophages promote collagen fibrillogenesis around terminal end buds of the developing mammary gland , 2006, Developmental dynamics : an official publication of the American Association of Anatomists.

[234]  Romayne A. Thompson,et al.  Age-related lobular involution and risk of breast cancer. , 2006, Journal of the National Cancer Institute.

[235]  J. Erler,et al.  Lysyl oxidase mediates hypoxic control of metastasis. , 2006, Cancer research.

[236]  Z. Werb,et al.  Hormonal and local control of mammary branching morphogenesis. , 2006, Differentiation; research in biological diversity.

[237]  B. Alicke,et al.  The Rho kinase inhibitor fasudil inhibits tumor progression in human and rat tumor models , 2006, Molecular Cancer Therapeutics.

[238]  A. Friedl,et al.  Syndecan-1 expression by stromal fibroblasts promotes breast carcinoma growth in vivo and stimulates tumor angiogenesis , 2006, Oncogene.

[239]  P. Chambon,et al.  Paracrine signaling through the epithelial estrogen receptor α is required for proliferation and morphogenesis in the mammary gland , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[240]  Jeannette Bigler,et al.  Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics , 2006, Nature Reviews Cancer.

[241]  Jeffrey M. Rosen,et al.  Pleiotropic effects of FGFR1 on cell proliferation, survival, and migration in a 3D mammary epithelial cell model , 2005, The Journal of cell biology.

[242]  E. van Marck,et al.  Angiogenesis and hypoxia in lymph node metastases is predicted by the angiogenesis and hypoxia in the primary tumour in patients with breast cancer , 2005, British Journal of Cancer.

[243]  R. Sormunen,et al.  Lysyl oxidase is essential for normal development and function of the respiratory system and for the integrity of elastic and collagen fibers in various tissues. , 2005, The American journal of pathology.

[244]  M. Lishner,et al.  Non‐steroidal anti‐inflammatory drugs for the prevention and treatment of cancer , 2005, Journal of internal medicine.

[245]  J. Peterse,et al.  Breast cancer metastasis: markers and models , 2005, Nature Reviews Cancer.

[246]  Dennis C. Sgroi,et al.  Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion , 2005, Cell.

[247]  E. Petricoin,et al.  Adipocyte-derived collagen VI affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor/stroma microenvironment. , 2005, The Journal of clinical investigation.

[248]  P. Bonnier,et al.  Overexpression of hypoxia‐inducible factor HIF‐1α predicts early relapse in breast cancer: Retrospective study in a series of 745 patients , 2005, International journal of cancer.

[249]  P. Schedin,et al.  Mammary ECM composition and function are altered by reproductive state , 2004, Molecular carcinogenesis.

[250]  D. Piwnica-Worms,et al.  CXCR4 Regulates Growth of Both Primary and Metastatic Breast Cancer , 2004, Cancer Research.

[251]  Jose Russo,et al.  Development of the human breast. , 2004, Maturitas.

[252]  S. Nie,et al.  Inhibition of Breast Cancer Metastasis by Selective Synthetic Polypeptide against CXCR4 , 2004, Cancer Research.

[253]  Ruud H. Brakenhoff,et al.  Dissecting the metastatic cascade , 2004, Nature Reviews Cancer.

[254]  R. Weinberg,et al.  Reconstruction of functionally normal and malignant human breast tissues in mice. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[255]  P. Goss,et al.  The role of COX-2 inhibition in breast cancer treatment and prevention. , 2004, Seminars in oncology.

[256]  Takako Sasaki,et al.  Laminin: the crux of basement membrane assembly. , 2004, The Journal of cell biology.

[257]  A. Otaka,et al.  T140 analogs as CXCR4 antagonists identified as anti‐metastatic agents in the treatment of breast cancer , 2003, FEBS letters.

[258]  Peter Friedl,et al.  Compensation mechanism in tumor cell migration , 2003, The Journal of cell biology.

[259]  G. Tuszynski,et al.  Fibroblasts promote breast cancer cell invasion by upregulating tumor matrix metalloproteinase-9 production. , 2002, Surgery.

[260]  Kazuki Nabeshima,et al.  Matrix metalloproteinases in tumor invasion: Role for cell migration , 2002, Pathology international.

[261]  M. V. van Oers,et al.  Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma. , 2002, Blood.

[262]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[263]  B. Hinz,et al.  Alpha-smooth muscle actin expression upregulates fibroblast contractile activity. , 2001, Molecular biology of the cell.

[264]  E. Howard,et al.  Transforming growth factor-beta1 promotes the morphological and functional differentiation of the myofibroblast. , 2000, Experimental cell research.

[265]  K. Seibert,et al.  Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor. , 2000, Cancer research.

[266]  H. Hibshoosh,et al.  Induction of autophagy and inhibition of tumorigenesis by beclin 1 , 1999, Nature.

[267]  M. J. Stanley,et al.  Syndecan-1 expression is induced in the stroma of infiltrating breast carcinoma. , 1999, American journal of clinical pathology.

[268]  R. Weinberg,et al.  A paracrine role for the epithelial progesterone receptor in mammary gland development. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[269]  L. Orci,et al.  Roles of Hepatocyte Growth Factor/Scatter Factor and Transforming Growth Factor-β1 in Mammary Gland Ductal Morphogenesis , 1998, Journal of Mammary Gland Biology and Neoplasia.

[270]  G. Stamp,et al.  Fibroblast growth factor receptor signalling has a role in lobuloalveolar development of the mammary gland. , 1997, Journal of cell science.

[271]  C. Larabell,et al.  Reversion of the Malignant Phenotype of Human Breast Cells in Three-Dimensional Culture and In Vivo by Integrin Blocking Antibodies , 1997, The Journal of cell biology.

[272]  G. Colditz,et al.  Prospective study of regular aspirin use and the risk of breast cancer. , 1996, Journal of the National Cancer Institute.

[273]  V. Nguyen,et al.  Occult deposition of eosinophil peroxidase in a subset of human breast carcinomas. , 1996, The American journal of pathology.

[274]  M. Bissell,et al.  The origin of the myofibroblasts in breast cancer. Recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells. , 1995, The Journal of clinical investigation.

[275]  R. Tarone,et al.  On the possible role of involution in the natural history of breast cancer , 1993 .

[276]  Z. Werb,et al.  Coordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involution , 1992, The Journal of cell biology.

[277]  W. Schürch,et al.  Smooth‐muscle differentiation in stromal cells of malignant and non‐malignant breast tissues , 1988, International journal of cancer.

[278]  A Ahmed,et al.  Stromal changes in invasive breast carcinoma: An ultrastructural study , 1987, The Journal of pathology.

[279]  C C Bird,et al.  Morphometric studies of age related changes in normal human breast and their significance for evolution of mammary cancer. , 1985, Journal of clinical pathology.

[280]  H. Bern,et al.  Development of mammary tumors from hyperplastic alveolar nodules transplanted into gland-free mammary fat pads of female C3H mice. , 1959, Cancer research.

[281]  Zuzana Koledova,et al.  3D Coculture of Mammary Organoids with Fibrospheres: A Model for Studying Epithelial-Stromal Interactions During Mammary Branching Morphogenesis. , 2017, Methods in molecular biology.

[282]  Jihe Zhao,et al.  The Role of chemokine receptor CXCR4 in breast cancer metastasis. , 2013, American journal of cancer research.

[283]  Suyun Huang,et al.  Vascular endothelial growth factor expression promotes the growth of breast cancer brain metastases in nude mice , 2004, Clinical & Experimental Metastasis.

[284]  E. Lander,et al.  A molecular signature of metastasis in primary solid tumors , 2003, Nature Genetics.

[285]  M. Götte,et al.  Functions of cell surface heparan sulfate proteoglycans. , 1999, Annual review of biochemistry.